Drug:
Reaction: DECREASED APPETITE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940173 |
CO |
59 | 2 |
General physical health deterioration, Decreased appetite, Weight decreased, Dehydration, Vomiting, |
||||
LIRAGLUTIDE, |
||||
| 2 | 26940402 |
US |
70 | 2 |
Decreased appetite, Asthenia, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 3 | 26940411 |
EU |
2 | |
Dysdiadochokinesis, Headache, Hypoaesthesia, Metastases to peritoneum, Polyneuropathy, Adenocarcinoma, Metastases to liver, Breast mass, Arthralgia, Alopecia, Upper respiratory tract infection, Decreased appetite, Nausea, Vomiting, Depression, Lung opacity, Pleural thickening, Pelvic fluid collection, |
||||
TRASTUZUMAB, DURVALUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, |
||||
| 4 | 26940463 |
US |
70 | 2 |
Impaired gastric emptying, Abdominal pain upper, Decreased appetite, Diarrhoea, Pruritus, Dyspnoea, |
||||
AGALSIDASE BETA, |
||||
| 5 | 26940540 |
US |
61 | 2 |
Abdominal discomfort, Decreased appetite, Unevaluable event, Viral infection, Malaise, Vomiting, Abdominal pain, |
||||
ABALOPARATIDE, EXTENDED PHENYTOIN SODIUM, GABAPENTIN, DIVALPROEX SODIUM, CENOBAMATE, |
||||
| 6 | 26940575 |
CA |
49 | 2 |
Angina pectoris, Abdominal discomfort, Asthenia, Cough, Decreased appetite, Dehydration, Dyspnoea exertional, Gastrointestinal disorder, General physical health deterioration, Inflammation, Influenza like illness, Presyncope, Productive cough, Abdominal pain, Abdominal pain upper, Constipation, Diarrhoea, Fatigue, Headache, Nasopharyngitis, Nausea, Oral fungal infection, Upper respiratory tract infection, Viral infection, Condition aggravated, Pain, Rhinorrhoea, Therapeutic product effect delayed, Therapeutic response shortened, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 7 | 26940610 |
CA |
22 | 1 |
Abdominal pain upper, Anal fistula, Decreased appetite, Fistula, Fistula discharge, Weight decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 8 | 26940808 |
US |
2 | |
Inflammation, Nausea, Fatigue, Arthralgia, Abdominal distension, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 9 | 26940889 |
CN |
33 | 1 |
Neutrophil count decreased, Chest discomfort, Asthenia, Nausea, Vomiting, White blood cell count decreased, Haemoglobin decreased, Decreased appetite, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, PEGASPARGASE, OXALIPLATIN, |
||||
| 10 | 26940921 |
US |
2 | |
Tremor, Blood potassium increased, Decreased appetite, Insomnia, Hypertension, Arthralgia, |
||||
ABALOPARATIDE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 11 | 26940990 |
US |
2 | |
Taste disorder, Weight decreased, Decreased appetite, Blood pressure increased, Nausea, Headache, Rash, Dizziness, Alopecia, Dry skin, |
||||
ABALOPARATIDE, |
||||
| 12 | 26941076 |
US |
2 | |
Muscle spasms, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 13 | 26941107 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 14 | 26941173 |
US |
2 | |
Decreased appetite, Fatigue, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 15 | 26941198 |
1 | ||
Anger, Decreased appetite, |
||||
VIGABATRIN, |
||||
| 16 | 26941201 |
CN |
18 | 2 |
Palpitations, Nausea, Vomiting, Dizziness, Inappropriate schedule of product administration, Chest discomfort, Decreased appetite, |
||||
PIOGLITAZONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 17 | 26941253 |
US |
77 | 2 |
Retinal detachment, Fatigue, Off label use, Decreased appetite, Taste disorder, Alopecia, Eye swelling, Diplopia, Visual impairment, Lacrimation increased, Unevaluable event, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 18 | 26941271 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
TIRZEPATIDE, |
||||
| 19 | 26941349 |
EU |
55 | 2 |
Rash, Pain, Cognitive disorder, Apathy, Asthenia, Decreased appetite, |
||||
OLANZAPINE, SERTRALINE HYDROCHLORIDE, |
||||
| 20 | 26941495 |
US |
2 | |
Nervousness, Balance disorder, Hyperhidrosis, Oral pain, Decreased appetite, Dizziness, Heart rate increased, Headache, Malaise, Fatigue, Palpitations, Bone pain, |
||||
ABALOPARATIDE, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, |
||||
| 21 | 26941509 |
US |
30 | 2 |
Decreased appetite, Nausea, Abdominal pain, |
||||
ORFORGLIPRON, |
||||
| 22 | 26941515 |
US |
2 | |
Hypoacusis, Decreased appetite, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 23 | 26941520 |
85 | ||
Somnolence, Decreased appetite, |
||||
QUETIAPINE, DONEPEZIL HYDROCHLORIDE, RAMELTEON, |
||||
| 24 | 26941672 |
US |
63 | 2 |
Emotional disorder, Presyncope, Dyspnoea, Asthenia, Diarrhoea, Fatigue, Headache, Decreased appetite, Perioral dermatitis, Rash, |
||||
VANDETANIB, VENLAFAXINE HYDROCHLORIDE, |
||||
| 25 | 26941777 |
US |
1 | |
Taste disorder, Dizziness, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 26 | 26941823 |
US |
2 | |
Muscle twitching, Somnolence, Dizziness postural, Nocturia, Orthostatic hypertension, Depressed mood, Depression, Amnesia, Pollakiuria, Mood altered, Decreased appetite, Fatigue, Palpitations, Heart rate increased, Dizziness, Diarrhoea, Insomnia, Asthenia, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 27 | 26941883 |
US |
2 | |
Brain fog, Decreased appetite, Nausea, Dizziness, |
||||
ABALOPARATIDE, |
||||
| 28 | 26941884 |
CA |
43 | 2 |
Breast cancer stage II, Asthenia, Dislocation of vertebra, Arthralgia, Gait inability, Malaise, Fluid retention, Rheumatoid factor positive, Urticaria, Joint swelling, Synovitis, Asthma, Hand deformity, Mobility decreased, Decreased appetite, Systemic lupus erythematosus, Wound, Rheumatoid arthritis, Lower limb fracture, Injury, Drug hypersensitivity, Road traffic accident, Musculoskeletal pain, Pemphigus, Blood cholesterol increased, Sciatica, Drug intolerance, Liver disorder, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, OXYCODONE, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 29 | 26941960 |
US |
2 | |
Decreased appetite, Lethargy, Asthenia, Nausea, |
||||
TIRZEPATIDE, ATENOLOL, LOSARTAN, |
||||
| 30 | 26941982 |
JP |
70 | 1 |
Oesophageal ulcer, Decreased appetite, Taste disorder, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, PRASUGREL HYDROCHLORIDE, ZINC ACETATE, CARVEDILOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, FOLIC ACID, ROSUVASTATIN, LANSOPRAZOLE, |
||||
| 31 | 26941990 |
US |
1 | |
Fall, Decreased appetite, Asthenia, Ill-defined disorder, |
||||
SOTORASIB, |
||||
| 32 | 26942277 |
US |
1 | |
Skin discolouration, Decreased appetite, Abdominal pain, Dysstasia, Herpes zoster, Speech disorder, |
||||
RAVULIZUMAB, PREDNISONE, |
||||
| 33 | 26942392 |
US |
0 | 2 |
Pneumonia, Pyrexia, Decreased appetite, Cough, |
||||
ELAPEGADEMASE-LVLR, |
||||
| 34 | 26942485 |
US |
2 | |
Decreased appetite, Injection site discolouration, |
||||
ORAL SEMAGLUTIDE, |
||||
| 35 | 26942598 |
US |
59 | 2 |
Decreased appetite, |
||||
ORAL SEMAGLUTIDE, |
||||
| 36 | 26942622 |
US |
68 | 1 |
Flatulence, Abdominal distension, Decreased appetite, Abdominal pain upper, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, INSULIN GLARGINE, |
||||
| 37 | 26942814 |
US |
74 | 2 |
Muscle fatigue, Decreased appetite, Nausea, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 38 | 26942897 |
CN |
||
Decreased appetite, Gastrointestinal disorder, Myelosuppression, Hepatic function abnormal, Renal impairment, Proteinuria, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 39 | 26943012 |
IN |
49 | 1 |
Decreased appetite, Diarrhoea, Abdominal pain, C-reactive protein increased, |
||||
| 40 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 41 | 26943212 |
US |
2 | |
Renal failure, Myalgia, Hot flush, Parosmia, Sinus congestion, Eye swelling, Lymphopenia, Alopecia, Dysgeusia, Decreased appetite, Nausea, |
||||
ABEMACICLIB, |
||||
| 42 | 26943387 |
TW |
64 | 2 |
Lung adenocarcinoma stage IV, Malignant neoplasm progression, Diarrhoea, Decreased appetite, Rash, Mucosal inflammation, Swelling of eyelid, Off label use, |
||||
TRAMETINIB, TRAMETINIB, TRAMETINIB, TRAMETINIB, GEFITINIB, GEFITINIB, |
||||
| 43 | 26943518 |
US |
13 | 1 |
Tricuspid valve incompetence, Somnolence, Fatigue, Heart rate increased, Decreased appetite, Cardiac ablation, Arrhythmia, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 44 | 26943565 |
US |
32 | 2 |
Dehydration, Nausea, Hypophagia, Abdominal rigidity, Weight decreased, Decreased appetite, Constipation, Abdominal pain, Vomiting, Diarrhoea, Abdominal discomfort, |
||||
TIRZEPATIDE, |
||||
| 45 | 26943917 |
EU |
54 | 1 |
Arthralgia, Pyrexia, Cough, Infection, Decreased appetite, Fatigue, Diarrhoea, |
||||
LENALIDOMIDE, |
||||
| 46 | 26944022 |
GB |
82 | 2 |
Confusional state, Decreased appetite, Headache, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, MENTHOL, COUGH SUPPRESSANT, 2%MENTHOL, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, COUGH SUPPRESSANT, 2%MENTHOL, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, COUGH SUPPRESSANT, 2%MENTHOL, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, COUGH SUPPRESSANT, 2%MENTHOL, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, BUMETANIDE, BUMETANIDE, BUMETANIDE, BUMETANIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LOSARTAN, LOSARTAN, LOSARTAN, LOSARTAN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, METHENAMINE HIPPURATE, METHENAMINE HIPPURATE, METHENAMINE HIPPURATE, METHENAMINE HIPPURATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CEPHALEXIN, CEPHALEXIN, CEPHALEXIN, CEPHALEXIN, |
||||
| 47 | 26944092 |
EU |
74 | 2 |
Syncope, Pyelonephritis, Suprapubic pain, Pyrexia, Pain, Chills, Bacteraemia, Alopecia, Anxiety, Diarrhoea, COVID-19, Pyrexia, Malaise, Limb discomfort, Decreased appetite, Dysgeusia, Lung opacity, Haemoglobin decreased, Red blood cell count decreased, Haematocrit decreased, Mean cell volume increased, Mean cell haemoglobin increased, White blood cell count decreased, Glomerular filtration rate decreased, Alanine aminotransferase decreased, Blood urea increased, Blood creatinine increased, Peripheral swelling, Pain in extremity, Bladder discomfort, Dysuria, Dizziness, Influenza, Hypotension, Depressed mood, Breast mass, Affect lability, Tearfulness, Bone scan abnormal, Asthenia, Pain in jaw, Decreased immune responsiveness, Laboratory test abnormal, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 48 | 26944362 |
CA |
44 | 2 |
Liver injury, Folliculitis, Gait inability, Headache, Nasopharyngitis, Night sweats, Lower respiratory tract infection, Musculoskeletal pain, Lung disorder, Impaired healing, Hand deformity, Muscle injury, Intentional product use issue, Hypersensitivity, Drug hypersensitivity, Glossodynia, Hypoaesthesia, Fatigue, Helicobacter infection, Musculoskeletal stiffness, Muscle spasms, Injury, Lower limb fracture, Joint swelling, Facet joint syndrome, Gastrointestinal disorder, Fibromyalgia, Drug intolerance, Deep vein thrombosis postoperative, Decreased appetite, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 49 | 26944415 |
CA |
38 | |
Muscle spasms, Hypotension, Dizziness, Pain, Nausea, Oropharyngeal pain, Rhinorrhoea, Nasal congestion, Malaise, Decreased appetite, Abdominal discomfort, Frequent bowel movements, Nasopharyngitis, Abdominal pain, Fatigue, Pyrexia, Headache, Underdose, |
||||
INFLIXIMAB-DYYB, BUDESONIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 50 | 26944430 |
US |
55 | 1 |
Decreased appetite, Weight decreased, Taste disorder, Oral pain, Nausea, Constipation, Abdominal pain upper, Vision blurred, Blood pressure fluctuation, |
||||
NIVOLUMAB, CABOZANTINIB, |
||||
| 51 | 26944515 |
US |
35 | 1 |
Death, Weight decreased, Decreased appetite, Coordination abnormal, Fall, Off label use, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 52 | 26944566 |
US |
71 | 2 |
Hypersensitivity, Decreased appetite, Cough, Primary cough headache, Hypoaesthesia, Sinus disorder, Fatigue, Asthenia, |
||||
ENASIDENIB MESYLATE, |
||||
| 53 | 26944725 |
US |
2 | |
Decreased appetite, Fatigue, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 54 | 26944731 |
US |
1 | |
Somnolence, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 55 | 26944748 |
US |
2 | |
Decreased appetite, Back pain, Headache, Heart rate increased, Tachycardia, Injection site haemorrhage, Wrong technique in device usage process, |
||||
ABALOPARATIDE, |
||||
| 56 | 26944827 |
18 | ||
Lafora^s myoclonic epilepsy, Condition aggravated, Drug-disease interaction, Mood swings, Irritability, Sedation complication, Cognitive disorder, Weight decreased, Decreased appetite, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, TOPIRAMATE, VALPROATE SODIUM, VALPROATE SODIUM, CLOBAZAM, PHENYTOIN, PHENOBARBITAL, FOLIC ACID, MAGNESIUM, CALCIUM, ERGOCALCIFEROL, PERAMPANEL, PERAMPANEL, CARBAMAZEPINE, |
||||
| 57 | 26944870 |
US |
2 | |
Decreased appetite, Headache, Nausea, Injection site bruising, Dizziness, |
||||
ABALOPARATIDE, |
||||
| 58 | 26944886 |
BR |
24 | 2 |
Thrombotic microangiopathy, Haemolysis, Hypertension, Schistocytosis, Lethargy, Decreased appetite, Thrombocytopenia, Haemolytic anaemia, |
||||
| 59 | 26944940 |
US |
1 | |
Weight loss poor, Decreased appetite, |
||||
| 60 | 26945026 |
US |
2 | |
Somnolence, Illness, Blood pressure decreased, Decreased appetite, Injection site pain, Injection site erythema, Injection site swelling, Back pain, Nausea, Dizziness, Fatigue, |
||||
ABALOPARATIDE, FEXOFENADINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, DIPHENHYDRAMINE HYDROCHLORIDE, CALCIUM, FISH OIL, FLUTICASONE PROPIONATE, LORAZEPAM, POLYETHYLENE GLYCOL 3350, MONTELUKAST, RIMEGEPANT SULFATE, MAGNESIUM, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM AND SENNOSIDES, SENNOSIDES AND DOCUSATE SODIUM, DOCUSATE SODIUM SENNOSIDES, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 61 | 26945051 |
US |
||
Decreased appetite, Pyrexia, Nausea, Vomiting, Diarrhoea, Headache, |
||||
ABALOPARATIDE, EPINEPHRINE, ADRENALINUM, |
||||
| 62 | 26945165 |
63 | ||
Off label use, Sensory disturbance, Swelling face, Swelling face, Eye swelling, Erythema, Feeling abnormal, Hypoaesthesia, Hypoaesthesia, Weight decreased, Decreased appetite, Anxiety, Skin tightness, Skin burning sensation, Colitis ulcerative, Oral discomfort, |
||||
HYALURONIDASE, HYALURONIDASE, HYALURONIDASE, |
||||
| 63 | 26945170 |
US |
1 | |
Weight decreased, Decreased appetite, Nausea, |
||||
ABALOPARATIDE, |
||||
| 64 | 26945237 |
US |
2 | |
Night sweats, Areflexia, COVID-19, Negative thoughts, Decreased appetite, Bone pain, Fatigue, Nausea, Dyspnoea, Product dose omission in error, Product prescribing issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, BUPRENORPHINE, BUSPIRONE HYDROCHLORIDE, LATANOPROST, PANTOPRAZOLE, PAROXETINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 65 | 26945410 |
US |
2 | |
Anxiety, Affective disorder, Depression, Irritability, Head discomfort, Decreased appetite, Nausea, |
||||
ABALOPARATIDE, |
||||
| 66 | 26945740 |
US |
2 | |
Nausea, Decreased appetite, Fatigue, Dizziness, |
||||
SPARSENTAN, |
||||
| 67 | 26945788 |
US |
2 | |
Pollakiuria, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 68 | 26945857 |
US |
22 | 2 |
Nausea, Abdominal discomfort, Decreased appetite, Abdominal distension, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 69 | 26946076 |
US |
2 | |
Decreased appetite, Nausea, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 70 | 26946162 |
US |
1 | |
Sedation, Personality change, Decreased appetite, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 71 | 26946198 |
US |
2 | |
Decreased appetite, Headache, Heart rate increased, Product dispensing issue, |
||||
ABALOPARATIDE, |
||||
| 72 | 26946256 |
US |
2 | |
Ear pain, Decreased appetite, Nausea, Headache, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 73 | 26946272 |
US |
2 | |
Weight decreased, Decreased appetite, Nausea, Injection site bruising, Intentional dose omission, |
||||
ABALOPARATIDE, |
||||
| 74 | 26946382 |
US |
2 | |
Alopecia, Decreased appetite, Vertigo, Palpitations, Dizziness, Heart rate increased, Headache, |
||||
ABALOPARATIDE, |
||||
| 75 | 26946384 |
US |
2 | |
Flushing, Hyperhidrosis, Irritable bowel syndrome, Decreased appetite, Nausea, Headache, Injection site pain, Fatigue, Asthenia, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TIRZEPATIDE, |
||||
| 76 | 26946421 |
US |
2 | |
Decreased appetite, Hypotension, |
||||
SPARSENTAN, |
||||
| 77 | 26946438 |
US |
76 | 2 |
Decreased appetite, Diarrhoea, |
||||
ABALOPARATIDE, |
||||
| 78 | 26946469 |
US |
2 | |
Weight increased, Erythema, Decreased appetite, Muscle spasms, Contusion, |
||||
ABALOPARATIDE, |
||||
| 79 | 26946649 |
US |
24 | 1 |
Blood potassium decreased, Illness, Decreased appetite, Blood calcium increased, Nausea, |
||||
ABALOPARATIDE, |
||||
| 80 | 26946697 |
US |
2 | |
Decreased appetite, Weight decreased, Headache, Muscle spasms, Fatigue, Incorrect dose administered, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 81 | 26946794 |
US |
67 | 2 |
Injection site urticaria, Weight decreased, Decreased appetite, Injection site erythema, Injection site pruritus, Fatigue, Bone pain, Headache, Pain in extremity, Diarrhoea, Dizziness, Blood calcium increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 82 | 26946855 |
US |
77 | 2 |
Upper respiratory tract infection, Hypotension, Decreased appetite, Fatigue, |
||||
ABALOPARATIDE, CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, |
||||
| 83 | 26946869 |
US |
2 | |
Decreased appetite, Drug intolerance, Palpitations, Bone pain, Nausea, Vertigo, Headache, Motion sickness, Intentional product misuse, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 84 | 26947042 |
US |
2 | |
Weight decreased, Decreased appetite, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 85 | 26947081 |
US |
2 | |
Somnolence, Abnormal dreams, Chest discomfort, Feeling abnormal, Decreased appetite, Dyspnoea, Fatigue, Nausea, Product dose omission issue, |
||||
ABALOPARATIDE, METHYL SALICYLATE, METHYL SALICYLATE 10%, CEFDINIR, LINACLOTIDE, MELOXICAM, BISMUTH SUBSALICYLATE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, MENTHOL, CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL, |
||||
| 86 | 26947265 |
US |
71 | 2 |
COVID-19, Hyperhidrosis, Chills, Decreased appetite, Dizziness, Fatigue, Headache, |
||||
ABALOPARATIDE, |
||||
| 87 | 26947301 |
US |
62 | 2 |
Discomfort, Decreased appetite, Dyspnoea, Dizziness, Palpitations, Arthralgia, Bone pain, Fatigue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 88 | 26947349 |
CA |
43 | |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Nasopharyngitis, Sinusitis, Wound infection, Drug intolerance, Treatment failure, Contraindicated product administered, Off label use, Product use in unapproved indication, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 89 | 26947395 |
US |
2 | |
Flushing, Feeling hot, Ageusia, Decreased appetite, Fatigue, Pain, Headache, Nausea, Palpitations, Dizziness, Blood calcium increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 90 | 26947449 |
US |
59 | 2 |
Decreased appetite, Arthralgia, Arthralgia, Back pain, Heart rate increased, Nausea, Dizziness, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, BIOTIN, CALCIUM, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 91 | 26947515 |
CO |
63 | 1 |
Asthenia, Generalised oedema, Decreased appetite, Platelet count decreased, Fatigue, |
||||
OSIMERTINIB, |
||||
| 92 | 26947525 |
US |
2 | |
Heart rate irregular, Decreased appetite, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 93 | 26947547 |
US |
2 | |
Decreased appetite, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 94 | 26947555 |
US |
2 | |
Flatulence, Decreased appetite, Abdominal distension, Nausea, Bone pain, Vertigo, Fatigue, Headache, |
||||
ABALOPARATIDE, |
||||
| 95 | 26947599 |
US |
2 | |
Unevaluable event, Head discomfort, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 96 | 26947612 |
US |
2 | |
Sensory disturbance, Decreased appetite, Headache, Back pain, Palpitations, Product administered at inappropriate site, |
||||
ABALOPARATIDE, |
||||
| 97 | 26947630 |
US |
2 | |
Nausea, Decreased appetite, Diarrhoea, Fatigue, Weight decreased, Insomnia, |
||||
TEPROTUMUMAB, |
||||
| 98 | 26947856 |
US |
75 | 2 |
Myalgia, Gastrointestinal sounds abnormal, Decreased appetite, Abdominal discomfort, Abdominal pain upper, Arthralgia, Headache, Pain, Asthenia, Unevaluable event, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, PSYLLIUM HUSK, |
||||
| 99 | 26947910 |
US |
2 | |
Decreased appetite, Hot flush, Headache, Injection site bruising, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 100 | 26947972 |
US |
2 | |
Emotional distress, Flushing, Glossitis, Blood pressure increased, Decreased appetite, Fatigue, Bone pain, Constipation, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30